In response to the growing demand for high-quality, scalable lentiviral vectors crucial in advancing innovative gene therapies, Wacker Biotech US Inc., a wholly owned subsidiary of Wacker Chemie AG specializing in plasmid DNA (pDNA) production, and Expression Manufacturing, a leader in viral vector technology, have entered into a strategic collaboration.